N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide

C152H132F12N36O13 — CID 161157364

IUPACN-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide
SMILESCCc1cc(-c2cccnc2)nn1-c1ccc(NC(=O)c2ccc(OCC3COCO3)nc2)cc1.Cc1cc(-c2cn(Cc3ccccc3)cn2)nn1-c1ccc(NC(=O)c2cccnc2)cc1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1cccnc1NCCCCCO.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1cccnc1NCCN1CCOCC1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1ccnc(NCCO)c1.O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3cncnc3)o2)cc1)c1cccnc1
InChIInChI=1S/C27H26F3N7O2.C26H25F3N6O2.C26H22N6O.C26H25N5O4.C24H15F3N6O2.C23H19F3N6O2/c28-27(29,30)24-17-23(19-3-1-9-31-18-19)35-37(24)21-7-5-20(6-8-21)34-26(38)22-4-2-10-32-25(22)33-11-12-36-13-15-39-16-14-36;27-26(28,29)23-16-22(18-6-4-12-30-17-18)34-35(23)20-10-8-19(9-11-20)33-25(37)21-7-5-14-32-24(21)31-13-2-1-3-15-36;1-19-14-24(25-17-31(18-28-25)16-20-6-3-2-4-7-20)30-32(19)23-11-9-22(10-12-23)29-26(33)21-8-5-13-27-15-21;1-2-21-12-24(18-4-3-11-27-13-18)30-31(21)22-8-6-20(7-9-22)29-26(32)19-5-10-25(28-14-19)34-16-23-15-33-17-35-23;25-24(26,27)22-10-19(21-8-7-20(35-21)16-12-29-14-30-13-16)33(32-22)18-5-3-17(4-6-18)31-23(34)15-2-1-9-28-11-15;24-23(25,26)20-13-19(16-2-1-8-27-14-16)31-32(20)18-5-3-17(4-6-18)30-22(34)15-7-9-28-21(12-15)29-10-11-33/h1-10,17-18H,11-16H2,(H,32,33)(H,34,38);4-12,14,16-17,36H,1-3,13,15H2,(H,31,32)(H,33,37);2-15,17-18H,16H2,1H3,(H,29,33);3-14,23H,2,15-17H2,1H3,(H,29,32);1-14H,(H,31,34);1-9,12-14,33H,10-11H2,(H,28,29)(H,30,34)
InChIKeyUPLYCNWGSRXJDQ-UHFFFAOYSA-N
MW2898.94 g/mol
LogP27.41
Rot. Bonds44

About N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide

N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide (PubChem CID 161157364) has the molecular formula C152H132F12N36O13 and a molecular weight of 2898.94 g/mol. Its IUPAC name is N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide.

Molecular Properties

Compound NameN-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide
PubChem CID161157364
Molecular FormulaC152H132F12N36O13
Molecular Weight2898.94 g/mol
Exact Mass2897.06
IUPAC NameN-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide
SMILESCCc1cc(-c2cccnc2)nn1-c1ccc(NC(=O)c2ccc(OCC3COCO3)nc2)cc1.Cc1cc(-c2cn(Cc3ccccc3)cn2)nn1-c1ccc(NC(=O)c2cccnc2)cc1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1cccnc1NCCCCCO.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1cccnc1NCCN1CCOCC1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1ccnc(NCCO)c1.O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3cncnc3)o2)cc1)c1cccnc1
InChIInChI=1S/C27H26F3N7O2.C26H25F3N6O2.C26H22N6O.C26H25N5O4.C24H15F3N6O2.C23H19F3N6O2/c28-27(29,30)24-17-23(19-3-1-9-31-18-19)35-37(24)21-7-5-20(6-8-21)34-26(38)22-4-2-10-32-25(22)33-11-12-36-13-15-39-16-14-36;27-26(28,29)23-16-22(18-6-4-12-30-17-18)34-35(23)20-10-8-19(9-11-20)33-25(37)21-7-5-14-32-24(21)31-13-2-1-3-15-36;1-19-14-24(25-17-31(18-28-25)16-20-6-3-2-4-7-20)30-32(19)23-11-9-22(10-12-23)29-26(33)21-8-5-13-27-15-21;1-2-21-12-24(18-4-3-11-27-13-18)30-31(21)22-8-6-20(7-9-22)29-26(32)19-5-10-25(28-14-19)34-16-23-15-33-17-35-23;25-24(26,27)22-10-19(21-8-7-20(35-21)16-12-29-14-30-13-16)33(32-22)18-5-3-17(4-6-18)31-23(34)15-2-1-9-28-11-15;24-23(25,26)20-13-19(16-2-1-8-27-14-16)31-32(20)18-5-3-17(4-6-18)30-22(34)15-7-9-28-21(12-15)29-10-11-33/h1-10,17-18H,11-16H2,(H,32,33)(H,34,38);4-12,14,16-17,36H,1-3,13,15H2,(H,31,32)(H,33,37);2-15,17-18H,16H2,1H3,(H,29,33);3-14,23H,2,15-17H2,1H3,(H,29,32);1-14H,(H,31,34);1-9,12-14,33H,10-11H2,(H,28,29)(H,30,34)
InChIKeyUPLYCNWGSRXJDQ-UHFFFAOYSA-N
XLogP27.41
TPSA583.87 Ų
H-Bond Donors11
H-Bond Acceptors43
Rotatable Bonds44
Heavy Atoms213
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002898.94
LogP ≤ 527.41
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide?
The IUPAC name of N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide (CID 161157364) is N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide.
What is the SMILES notation for N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide?
The canonical SMILES for N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide is CCc1cc(-c2cccnc2)nn1-c1ccc(NC(=O)c2ccc(OCC3COCO3)nc2)cc1.Cc1cc(-c2cn(Cc3ccccc3)cn2)nn1-c1ccc(NC(=O)c2cccnc2)cc1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1cccnc1NCCCCCO.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1cccnc1NCCN1CCOCC1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1)c1ccnc(NCCO)c1.O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3cncnc3)o2)cc1)c1cccnc1.
What is the InChIKey of N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide?
The InChIKey is UPLYCNWGSRXJDQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H26F3N7O2.C26H25F3N6O2.C26H22N6O.C26H25N5O4.C24H15F3N6O2.C23H19F3N6O2/c28-27(29,30)24-17-23(19-3-1-9-31-18-19)35-37(24)21-7-5-20(6-8-21)34-26(38)22-4-2-10-32-25(22)33-11-12-36-13-15-39-16-14-36;27-26(28,29)23-16-22(18-6-4-12-30-17-18)34-35(23)20-10-8-19(9-11-20)33-25(37)21-7-5-14-32-24(21)31-13-2-1-3-15-36;1-19-14-24(25-17-31(18-28-25)16-20-6-3-2-4-7-20)30-32(19)23-11-9-22(10-12-23)29-26(33)21-8-5-13-27-15-21;1-2-21-12-24(18-4-3-11-27-13-18)30-31(21)22-8-6-20(7-9-22)29-26(32)19-5-10-25(28-14-19)34-16-23-15-33-17-35-23;25-24(26,27)22-10-19(21-8-7-20(35-21)16-12-29-14-30-13-16)33(32-22)18-5-3-17(4-6-18)31-23(34)15-2-1-9-28-11-15;24-23(25,26)20-13-19(16-2-1-8-27-14-16)31-32(20)18-5-3-17(4-6-18)30-22(34)15-7-9-28-21(12-15)29-10-11-33/h1-10,17-18H,11-16H2,(H,32,33)(H,34,38);4-12,14,16-17,36H,1-3,13,15H2,(H,31,32)(H,33,37);2-15,17-18H,16H2,1H3,(H,29,33);3-14,23H,2,15-17H2,1H3,(H,29,32);1-14H,(H,31,34);1-9,12-14,33H,10-11H2,(H,28,29)(H,30,34).
What are the key properties of N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide?
N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide has a molecular weight of 2898.94 g/mol, XLogP of 27.41, 44 rotatable bonds, 11 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[3-(1-benzylimidazol-4-yl)-5-methylpyrazol-1-yl]phenyl]pyridine-3-carboxamide;6-(1,3-dioxolan-4-ylmethoxy)-N-[4-(5-ethyl-3-pyridin-3-ylpyrazol-1-yl)phenyl]pyridine-3-carboxamide;2-(2-hydroxyethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-4-carboxamide;2-(5-hydroxypentylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;2-(2-morpholin-4-ylethylamino)-N-[4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide;N-[4-[5-(5-pyrimidin-5-ylfuran-2-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]pyridine-3-carboxamide is sourced from PubChem (CID 161157364), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).